CSE/AAWH.U (CSE/AAWH.U)

Canadian Securities Exchange: CSE/AAWH.U · USD

$0.40

+0.00 (0.0%)· Recorded snapshot

Market cap	112.7M
Revenue (ttm)	693.5M
Net income (ttm)	-161.6M
EPS (ttm)	-$0.80
Shares out	203.3M
Volume	16,500
Beta	1.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 693.5M
Net income (ttm): -161.6M
EPS (ttm): -$0.80
Market cap: 112.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC0.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/AAWH.U indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-11-12
Employees	2,200
Employees change	-100
Employees growth	-4.35%
Enterprise value	$938.7M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2018
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	US04351N1063
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Market cap	$112.7M
Next earnings date	2026-11-12
Price	$0.40
Price currency	USD
Sector	Healthcare
SIC code	2833
Stock price date	2026-10-27
Symbol	cse/AAWH.U
Website	https://www.awholdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-143.86%
EV/EBIT	123.94x
EV/EBITDA	8.41x
EV/Sales	1.37x
FCF / EV yield	-1.05%
FCF yield	-8.75%
Industry forward P/E	34.53x
P/(OCF - SBC) ratio	5.26x
P/OCF ratio	4.58x
P/S ratio	0.16x
Price/EBITDA ratio	1.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.1%
EBITDA margin	9.86%
Gross margin	36.68%
Operating margin	1.1%
Pretax margin	-16.2%
Profit margin	-23.31%
Profit per employee	$-73,475
Revenue per employee	$315,218
ROA	0.38%
ROA (5Y)	0.72%
ROCE	0.7%
ROE (5Y)	-246.6%
ROIC	0.56%
SBC / revenue	0.46%
Tax / revenue	7.11%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
FCF growth (Q)	44.26%
Gross profit growth	4.4%
Gross profit growth (Q)	9.9%
Gross profit growth 3Y	6.42%
Gross profit growth 5Y	11.18%
OCF growth	-71.5%
OCF growth (Q)	26.12%
OCF growth 3Y	9.21%
Operating income growth	2.78%
Operating income growth 3Y	-4.38%
Operating income growth 5Y	-19.77%
Revenue growth	-8.37%
Revenue growth (Q)	-0.93%
Revenue growth (QoQ)	7.85%
Revenue growth 3Y	1.98%
Revenue growth 5Y	14.77%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-34.5M
Depreciation and amortization	$60M
EBIT	$7.7M
EBITDA	$68.4M
EPS	$-0.80
FCF per share	$-0.05
Financing cash flow	$2.2M
Free cash flow	$-9.9M
Free cash flow minus SBC	$-13.1M
Gross profit	$254.3M
Income taxes	$49.3M
Investing cash flow	$-66.9M
Net borrowing	$8.5M
Net cash flow	$-40.1M
Net income	$-161.6M
Operating cash flow minus SBC	$21.4M
Operating income	$7.7M
Revenue	$693.5M
Stock-based compensation	$3.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.14
Book value per share	$-0.60
Debt / EBITDA	8.24
Goodwill	$91.8M
Interest coverage	0.08
Long-term assets	$999.2M
Long-term liabilities	$1.2B
Net cash (debt)	$-834M
Net cash / market cap	-739.51%
Net debt / EBITDA	12.19
Piotroski F-Score	5
Property, plant and equipment	$601M
Shareholders' equity	$-120.8M
Tangible book value	$-493.1M
Tangible book value per share	$-2.43
Total assets	$1.3B
Total cash	$96.6M
Total debt	$930.6M
Total liabilities	$1.4B
WACC	8.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	$262.3M
Current liabilities	$158.1M
Current ratio	1.66
Inventory turnover	3.76
Net working capital	$54.1M
Quick ratio	0.84
Working capital	$105.4M
Working capital turnover	6.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.11%
Shareholder yield	3.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.48
1D price change	0%
1M price change	-33.05%
1M total return	-33.05%
1W price change	-0.63%
1W total return	-0.63%
1Y price change	-51.83%
1Y return CAGR	-51.85%
1Y total return	-51.83%
20-day SMA	$0.45
200-day SMA	$0.50
3M price change	1.28%
3M total return	1.28%
3Y price change	-57.98%
3Y return CAGR	-25.09%
3Y total return	-57.98%
50-day SMA	$0.47
50-day SMA vs 200-day SMA	50under200
52-week high	$1.20
52-week high date	2025-12-18
52-week low	$0.34
52-week low date	2026-08-06
5Y price change	-95.07%
5Y return CAGR	-45.23%
5Y total return	-95.07%
6M price change	-24.04%
6M total return	-24.04%
All-time high	$11.71
All-time high date	2021-06-21
All-time low	$0.24
All-time low date	2025-06-30
Average true range (ATR)	$0.03
Average volume	33.7K
Beta (1Y)	0.37
Beta (2Y)	1.11
Beta (5Y)	1.57
Change from 52-week high	-67.08%
Change from 52-week low	16.18%
Change from all-time high	-96.63%
Change from all-time low	64.58%
Change from open	0%
Day's gap	0%
Dollar volume	$6,518
High price	$0.40
Low price	$0.40
Monthly RSI	39.36
Open price	$0.40
Previous close	$0.40
Price vs 150-day SMA	-17.55%
Price vs 20-day SMA	-12.34%
Price vs 200-day SMA	-21.61%
Price vs 50-day SMA	-15.87%
Relative volume	0.49
RSI	37.97
Sharpe ratio	-0.01
Sharpe ratio (3Y)	0.21
Sharpe ratio (5Y)	-0.27
Sortino ratio	0.03
Sortino ratio (3Y)	0.38
Sortino ratio (5Y)	-0.34
Volume	16.5K
Weekly RSI	42.57
YTD price change	-47.33%
YTD total return	-47.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	140.1M
Shares change (QoQ)	0.28%
Shares change (YoY)	-3.11%
Shares held by insiders	6.02%
Shares held by institutions	0.41%
Shares outstanding	203.3M

Deeper analysis on CSE/AAWH.U

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/AAWH.U report

Is a complete CSE/AAWH.U research report available?

No complete published report is available for cse/AAWH.U (CSE/AAWH.U) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/AAWH.U (CSE/AAWH.U)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/AAWH.U

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/AAWH.U indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/AAWH.U

Frequently asked questions